Bypass Versus Drug-Eluting Stents at Three Years in SYNTAX Patients With Diabetes Mellitus or Metabolic Syndrome Michael J. Mack, MD, Adrian P. Banning,

Slides:

Advertisements

Similar presentations

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

Advertisements

Robert A. Guyton, MD The Annals of Thoracic Surgery

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Srikrishna Sirivella, MD, Isaac Gielchinsky,

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery Michael E. Halkos, MD,

Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac.

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction Paolo Nardi, MD, PhD, Antonio Pellegrino, MD, Antonio.

Similar Outcome in Insulin-Dependent and Noninsulin-Dependent Diabetic Patients After Off-Pump Coronary Artery Bypass Grafting With Multiple Skeletonized.

Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac.

Robert A. Guyton, MD The Annals of Thoracic Surgery

Advances in the treatment of coronary artery disease

Metabolic Syndrome Affects Midterm Outcome After Coronary Artery Bypass Grafting Emiliano Angeloni, MD, Giovanni Melina, PhD, Umberto Benedetto, PhD,

Preoperative Aspirin Use and Its Effect on Adverse Events in Patients Undergoing Cardiac Operations Jiapeng Huang, MD, PhD, Macarius Donneyong, PhD,

Predictors, Causes, and Consequences of Conversions in Robotically Enhanced Totally Endoscopic Coronary Artery Bypass Graft Surgery Thomas Schachner,

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy Takayuki Ohno, MD, Shinichi.

Unprotected Left Main Coronary Artery Stenting Versus Coronary Artery Bypass Graft Surgery Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Norikazu Kawai,

Peter K. Smith, MD The Annals of Thoracic Surgery

Hybrid Coronary Revascularization in 100 Patients With Multivessel Coronary Disease Alberto Repossini, MD, Maurizio Tespili, MD, Antonio Saino, MD, Lorenzo.

J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Does Diabetes Affect the Postoperative Outcomes After Total Arterial Off-Pump Coronary Bypass Surgery in Multivessel Disease? Jae-Sung Choi, MD, PhD,

Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention? Serenella Castelvecchio,

Ralf E. Harskamp, MD, Zhe Zheng, MD, PhD, John H

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery Michael E. Halkos, MD,

Four-Year Outcome of OPCAB No-Touch With Total Arterial Y-Graft: Making the Best Treatment a Daily Practice Wouter Bas Halbersma, MD, Sara Camilla Arrigoni,

The Society of Thoracic Surgeons Thoracic Surgery Practice and Access Task Force: 2014 Workforce Report John S. Ikonomidis, MD, PhD The Annals of Thoracic.

Off-Pump Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention: A Meta-Analysis of Randomized and Nonrandomized Studies J. James Edelman,

Ho Young Hwang, MD, Jun Sung Kim, MD, Ki-Bong Kim, MD, PhD

Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.

Influence of Diabetes Mellitus on Long-Term Clinical and Economic Outcomes After Coronary Artery Bypass Grafting Heng Zhang, MD, Xin Yuan, MD, PhD, Ruben.

Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients David C. Chang, PhD,

Ola A. Selnes, PhD, Maura A. Grega, MSN, Maryanne M

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Mariano E. Brizzio, MD, Alex Zapolanski, MD, Richard E

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Twenty-Year Single-Center Experience With the Medtronic Open Pivot Mechanical Heart Valve Guido J. Van Nooten, MD, PhD, Thierry Bové, MD, Yves Van Belleghem,

Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass for the Treatment of Left Main Coronary Stenosis Michael E. Halkos, MD, S. Tanveer.

Improved Outcomes of Total Arterial Myocardial Revascularization in Elderly Patients at Long-Term Follow-Up: A Propensity-Matched Analysis Gianluigi.

Long-Term Survival After Coronary Arterial Grafts in Patients With End-Stage Renal Disease Taro Nakatsu, MD, Nobushige Tamura, MD, PhD, Yutaka Sakakibara,

Long Segmental Reconstruction of Diffusely Diseased Left Anterior Descending Coronary Artery With Left Internal Thoracic Artery With or Without Endarterectomy

Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?

Complete Revascularization of the Three-Vessel Territories Using a Left Internal Thoracic Artery Composite Graft Ho Young Hwang, MD, PhD, Hong Chul Oh,

Yin-Shu Chang, MD, Jia-Xiang Wang, MD, PhD, Da-Wei Chang, PhD

Pure Bilateral Internal Thoracic Artery Grafting in Diabetic Patients With Triple-Vessel Disease Dong Seop Jeong, MD, PhD, Kiick Sung, MD, PhD, Young.

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

Influence of Diabetes Mellitus on Long-Term Survival in Systematic Off-Pump Coronary Artery Bypass Surgery Bertrand Marcheix, MD, Frédéric Vanden Eynden,

Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus Yanai Ben-Gal, MD, Yaron Moshkovitz, MD, Nachum Nesher,

Robotic Totally Endoscopic Coronary Artery Bypass Grafting in Men and Women: Are There Sex Differences in Outcome? Dominik Wiedemann, MD, Thomas Schachner,

Emergency Off-Pump Coronary Artery Bypass Graft Surgery for Patients on Preoperative Intraaortic Balloon Pump Hisato Ito, MD, Toru Mizumoto, MD, Hironori.

Current Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting Michael J. Mack, MD, Syma L. Prince, RN, Morley Herbert,

Severe Two-Vessel Ostial Stenosis of the Main Coronary Arteries in a Patient With Transposition of the Great Arteries After an Arterial Switch Operation

Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,

Effect of Diabetes on Outcome and Changes in Quality of Life After Coronary Artery Bypass Grafting Otso Järvinen, MD, PhD, Juhani Julkunen, PhD, Timo.

Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery Karl F. Welke, MD, Mitchell J. Barnett, PharmD,

First Report on 30-day and Operative Mortality in Risk Model of Isolated Coronary Artery Bypass Grafting in Japan Noboru Motomura, MD, PhD, Hiroaki Miyata,

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?

Aprotinin is Not Associated With Postoperative Renal Impairment After Primary Coronary Surgery Gabriella Lindvall, MD, Ulrik Sartipy, MD, PhD, Torbjörn.

On-Pump Versus Off-Pump Surgical Revascularization for Left Main Stem Stenosis: Risk Adjusted Outcomes John C.Y. Lu, Antony D. Grayson, BS, D. Mark Pullan

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Potassium and Magnesium Supplementation Do Not Protect Against Atrial Fibrillation After Cardiac Operation: A Time-Matched Analysis Timothy S. Lancaster,

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Impact of Diabetes on Five-Year Outcomes of Patients With Multivessel Coronary Artery Disease Whady Hueb, MD, Bernard J. Gersh, MB, ChB, Fernando Costa,

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

Mary E. Plomondon, PhD, Adrianne W. Casebeer, PhD, Lynn M

Magnus Dalén, MD, Torbjörn Ivert, MD, PhD, Martin J

Presentation transcript:

Bypass Versus Drug-Eluting Stents at Three Years in SYNTAX Patients With Diabetes Mellitus or Metabolic Syndrome Michael J. Mack, MD, Adrian P. Banning, MD, Patrick W. Serruys, MD, PhD, Marie-Claude Morice, MD, Yves Taeymans, MD, Guido Van Nooten, MD, PhD, Gianfederico Possati, MD, Filippo Crea, MD, Kristin L. Hood, PhD, Katrin Leadley, MD, Keith D. Dawkins, MD, A. Pieter Kappetein, MD, PhD The Annals of Thoracic Surgery Volume 92, Issue 6, Pages 2140-2146 (December 2011) DOI: 10.1016/j.athoracsur.2011.06.028 Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Patients included in the analysis. (A) Patients included in the diabetes mellitus analysis. (B) Overlap between diabetes and metabolic syndrome. (CABG = coronary artery bypass graft surgery; PES = paclitaxel-eluting stent.) The Annals of Thoracic Surgery 2011 92, 2140-2146DOI: (10.1016/j.athoracsur.2011.06.028) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Three-year outcomes for diabetic patients and nondiabetic patients according to anatomic lesion complexity, as measured by the SYNTAX score. (A, D) Major adverse cardiac and cerebrovascular events (MACCE), (B, E) composite death/cerebrovascular accident (CVA)/myocardial infarction (MI), and (C, F) revascularization in (A–C) patients with medically treated diabetes and (D–F) without medically treated diabetes. Rates are separated by SYNTAX Scores, indicating low (≤22), medium (23 to 32), and high (≥33) anatomic lesion complexity. (CABG = coronary artery bypass graft surgery [open bars]; PES = paclitaxel-eluting stent [solid bars].) The Annals of Thoracic Surgery 2011 92, 2140-2146DOI: (10.1016/j.athoracsur.2011.06.028) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions